Form 4 for EQIX Equinix
Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001127602-25-001442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-17 | 2025-01-16 | EQIX | MORANDI BRANDI GALVIN | CHRO | S - Sale+OE | $909.70 | -2,200 | 9,368 | -19% | -$2.00M |
| DM | 2025-01-17 | 2025-01-15 | EQIX | MORANDI BRANDI GALVIN | CHRO | M - OptEx | $0.00 | +4,344 | 7,882 | +123% | $0 |
| DM | 2025-01-17 | 2025-01-15 | EQIX | MORANDI BRANDI GALVIN | CHRO | M - OptEx | $0.00 | -4,344 | 1,532 | -74% | $0 |
| D | 2025-01-17 | 2025-01-15 | EQIX | MORANDI BRANDI GALVIN | CHRO | A - Grant | $0.00 | +1,377 | 1,377 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-16 | S | D | 80 | $900.07 | 10,769 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $899.30 to $900.25, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 10 to this Form 4. |
| 2 | Common | Common Stock | 2025-01-16 | S | D | 220 | $901.11 | 10,549 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $900.59 to $901.16 inclusive. |
| 3 | Common | Common Stock | 2025-01-16 | S | D | 200 | $902.80 | 10,349 | D | — | — | |
| 4 | Common | Common Stock | 2025-01-16 | S | D | 300 | $904.70 | 10,049 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $904.12 to $905.00 inclusive. |
| 5 | Common | Common Stock | 2025-01-16 | S | D | 300 | $908.26 | 9,749 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $907.74 to $908.55 inclusive. |
| 6 | Common | Common Stock | 2025-01-16 | S | D | 200 | $909.78 | 9,549 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $909.70 to $909.85 inclusive. |
| 7 | Common | Common Stock | 2025-01-16 | S | D | 135 | $915.41 | 9,233 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $915.00 to $915.83 inclusive. |
| 8 | Common | Common Stock | 2025-01-16 | S | D | 330 | $916.70 | 8,903 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $916.26 to $917.22 inclusive. |
| 9 | Common | Common Stock | 2025-01-16 | S | D | 254 | $917.65 | 8,649 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $917.42 to $917.87 inclusive. |
| 10 | Common | Common Stock | 2025-01-15 | M | A | 767 | $0.00 | 10,849 | D | — | — | |
| 11 | Common | Common Stock | 2025-01-15 | M | A | 1,118 | $0.00 | 10,082 | D | — | — | |
| 12 | Common | Common Stock | 2025-01-15 | M | A | 1,082 | $0.00 | 8,964 | D | — | — | |
| 13 | Common | Common Stock | 2025-01-15 | M | A | 1,377 | $0.00 | 7,882 | D | — | — | |
| 14 | Common | Common Stock | 2025-01-16 | S | D | 181 | $914.40 | 9,368 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $913.99 to $914.89 inclusive. |
| 15 | Derivative | Restricted Stock Units | 2025-01-15 | M | D | 1,377 | $0.00 | 0 | D | $0.00 · — to — | 1,377 Common Stock | (F11) On February 23, 2022, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the degree to which a relative Total Shareholder Return target was attained for the period January 1, 2022 to December 31, 2024. The Compensation Committee certified that the payout for this award would be 84.83% (out of a possible 100%) of the target to the reporting person based on the degree to which Equinix performed against the Russell 1000 Index (F12) Restricted stock unit award expires upon reporting person's termination of service. |
| 16 | Derivative | Restricted Stock Unit | 2025-01-15 | M | D | 1,082 | $0.00 | 0 | D | $0.00 · — to — | 1,082 Common Stock | (F13) Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2023 and an additional 33.33% of the RSUs will each vest on January 15, 2024 and January 15, 2025. (F12) Restricted stock unit award expires upon reporting person's termination of service. |
| 17 | Derivative | Restricted Stock Unit | 2025-01-15 | M | D | 1,118 | $0.00 | 1,117 | D | $0.00 · — to — | 1,118 Common Stock | (F14) Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2024 and an additional 33.33% of the RSUs will each vest on January 15, 2025 and January 15, 2026. (F12) Restricted stock unit award expires upon reporting person's termination of service. |
| 18 | Derivative | Restricted Stock Units | 2025-01-15 | A | A | 1,377 | $0.00 | 1,377 | D | $0.00 · — to — | 1,377 Common Stock | (F11) On February 23, 2022, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the degree to which a relative Total Shareholder Return target was attained for the period January 1, 2022 to December 31, 2024. The Compensation Committee certified that the payout for this award would be 84.83% (out of a possible 100%) of the target to the reporting person based on the degree to which Equinix performed against the Russell 1000 Index (F12) Restricted stock unit award expires upon reporting person's termination of service. |
| 19 | Derivative | Restricted Stock Unit | 2025-01-15 | M | D | 767 | $0.00 | 1,532 | D | $0.00 · — to — | 767 Common Stock | (F15) Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2025 and an additional 33.33% of the RSUs will each vest on January 15, 2026 and January 15, 2027. (F12) Restricted stock unit award expires upon reporting person's termination of service. |